Published in Women's Health Weekly, February 7th, 2002
AstraZeneca has already begun to provide the FDA data and plans to complete the rolling submission for Arimidex...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly